In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cracking Open the IPO Window for Pre-Commercial Device Companies

Executive Summary

DexCom's is a bellwether IPO: if it holds its value, it could open the door for other pre-commercial device businesses. If it doesn't, it could keep it shut-as it's been since the class of 1995-96 device companies disappointed investors by missing their commercial targets.
Advertisement

Related Content

Continuous Glucose Monitoring: A Revolution Powered by DexCom
Deal Statistics Quarterly, Q2 2005
Deal Statistics Quarterly, Q2 2005
Diabetes Monitoring Start-Ups:Building a Better Mousetrap or a Whole New Paradigm?
Cygnus' Comeback in Non-Invasive Testing
Cygnus' Comeback in Non-Invasive Testing
Animas Corp.
Animas Corp.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002560

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel